Article
A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients.
Cancer chemotherapy and pharmacology - 1 Feb 2009
Woodahl Erica L, Wang Joanne, Heimfeld Shelly, Sandmaier Brenda M, O'Donnell Paul V, Phillips Brian, Risler Linda, Blough David K, McCune Jeannine S
Abstract excerpt
PURPOSE: Fludarabine is an integral anticancer agent for patients with chronic lymphocytic leukemia (CLL) and those receiving conditioning regimens prior to allogeneic hematopoietic cell transplantation (HCT). An individual's response to fludarabine may be influenced by the amount of CD4(+) and CD8(+) T-lymphocyte suppression. Fludarabine undergoes cellular uptake and activation to form the cytotoxic metabolite,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
